Insights from 2024 WCLC
Playback speed
10 seconds
WCLC 2024 Insights: LAURA Study - Osimertinib After Definitive CRT in Unresectable Stage III EGFRm NSCLC
By
Insights from 2024 WCLC
FEATURING
Terufumi Kato
By
Insights from 2024 WCLC
FEATURING
Terufumi Kato
90 views
September 18, 2024
Login to view comments.
Click here to Login